E-LIB Suche - Ergebnisse für: Wiedemann, J.-Y.

1

Guidelines for the use of flow cytometry and cell sorting i..:

Cossarizza, A ; Chang, H ; Radbruch, A...
https://eprints.whiterose.ac.uk/184275/1/Eur%20J%20Immunol%20-%202021%20-%20Cossarizza%20-%20Guidelines%20for%20the%20use%20of%20flow%20cytometry%20and%20cell%20sorting%20in%20immunological%20studies%20.pdf. , 2021

Link: https://eprints.whiteros..

2

A randomized placebo-controlled efficacy study of a prime b..:

Levy, Y ; Lacabaratz, C ; Lhomme, Edouard...
info:eu-repo/semantics/altIdentifier/doi/10.1128/jvi.02165-20. , 2021

Link: https://hal.archives-ouv..

3

A randomized placebo-controlled efficacy study of a prime b..:

Levy, Y ; Lacabaratz, C ; Lhomme, Edouard...
info:eu-repo/semantics/altIdentifier/doi/10.1128/jvi.02165-20. , 2021

Link: https://hal.science/hal-..

4

The cytokines HGF and CXCL13 predict the severity and the m..:

Perreau, M ; Suffiotti, M ; Marques-Vidal, P...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41467-021-25191-5. , 2021

Link: https://serval.unil.ch/n..

5

Guidelines for the use of flow cytometry and cell sorting i..:

Cossarizza, A ; Chang, H-D ; Radbruch, A...
issn:0014-2980. , 2021

Link: http://hdl.handle.net/11..

6

Guidelines for the use of flow cytometry and cell sorting i..:

Cossarizza, A ; Chang, H.D ; Radbruch, A...
http://edoc.mdc-berlin.de/21279/1/21279oa.pdf. , 2021

Link: http://edoc.mdc-berlin.d..

7

Guidelines for the use of flow cytometry and cell sorting i..:

Cossarizza, A ; Chang, H-D ; Radbruch, A...
https://discovery.ucl.ac.uk/id/eprint/10142329/1/Eur%20J%20Immunol%20-%202021%20-%20Cossarizza%20-%20Guidelines%20for%20the%20use%20of%20flow%20cytometry%20and%20cell%20sorting%20in%20immunological%20studies%20.pdf. , 2021

Link: https://discovery.ucl.ac..

8

Guidelines for the use of flow cytometry and cell sorting i..:

Cossarizza A ; Chang H. -D ; Radbruch A...
info:eu-repo/semantics/altIdentifier/pmid/34910301. , 2021

Link: http://hdl.handle.net/11..

9

A randomized placebo-controlled efficacy study of a prime b..:

Levy, Y ; Lacabaratz, C ; Lhomme, Edouard...
info:eu-repo/semantics/altIdentifier/doi/10.1128/jvi.02165-20. , 2021

Link: https://hal.science/hal-..

10

Guidelines for the use of flow cytometry and cell sorting i..:

Cossarizza A ; Chang H. -D ; Radbruch A...
info:eu-repo/semantics/altIdentifier/pmid/34910301. , 2021

Link: http://hdl.handle.net/24..

11

A randomized placebo-controlled efficacy study of a prime b..:

LEVY, Y ; LACABARATZ, C ; LHOMME, Edouard...
0022-538x. , 2021

Link: https://oskar-bordeaux.f..

12

Safety and immunogenicity of a two-dose heterologous Ad26.Z..:

POLLARD, A. J ; LAUNAY, O ; LELIEVRE, J. D...
1474-4457 (Electronic) 1473-3099 (Linking). , 2020

Link: https://oskar-bordeaux.f..

13

Optimal priming of poxvirus vector (NYVAC)-based HIV vaccin..:

Lévy, Y ; Lacabaratz, C ; Ellefsen-Lavoie, K...
https://discovery.ucl.ac.uk/id/eprint/10103108/7/Optimal%20priming%20of%20poxvirus%20vector%20%28NYVAC%29-based%20HIV%20vaccine%20regimens%20for%20T%20cell%20responses%20requires%20three%20DNA%20injections.%20Re.pdf. , 2020

Link: https://discovery.ucl.ac..

14

Genetic and phenotypic spectrum associated with IFIH1 gain-..:

Rice G. I ; Park S ; Gavazzi F...
info:eu-repo/semantics/altIdentifier/pmid/31898846. , 2020

Link: https://hdl.handle.net/2..

15

Long-lasting severe immune dysfunction in Ebola virus disea..:

WIEDEMANN, A ; FOUCAT, E ; HOCINI, H...
2041-1723. , 2020

Link: https://oskar-bordeaux.f..